MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

A novel phenotype of amyloid precursor protein (APP) mutation presenting with dementia, and symptoms of both progressive supranulcear palsy (PSP) and multisystem atrophy (MSA)

J.E. Staisch, M. Padmanaban, J. Mastrianni, T. Xie (Chicago, IL, USA)

Meeting: 2016 International Congress

Abstract Number: 158

Keywords: Dementia, Multiple system atrophy(MSA): Genetics, Progressive supranuclear palsy(PSP)

Session Information

Date: Monday, June 20, 2016

Session Title: Parkinsonism, MSA, PSP (secondary and parkinsonism-plus)

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To describe the novel phenotype of a patient with an amyloid precursur protein (APP) mutation presenting with dementia and symptoms of both progressive supranulcear palsy (PSP) and multisystem atropy (MSA).

Background: Early dementia of AD phenotype is the most common presenting feature of patients with APP mutations. In human subjects, overlapping features of APP, PSP, and MSA have not previously been decribed in the literature.

Methods: We examined a 70 yo man with a history of four years of dementia, presenting with three years of akinetic-rigid parkinsonism and one year of autonomic dysfunction of urinary incontinence and orthostatic hypotension respectively. He had a family history of early onset (EOD) dementia in two out of four of his siblings and his mother. Mini-mental status exam was 2/30, During his clinic visit, he was orthostatic. MRI of the brain revealed moderate midbrain atrophy, but no hot-cross bun sign. B12 and TSH were WNL, and RPR negative. Gene testing revealed negative Presenillin 1 and 2, but he was positive for an APP disease-associated known mutation, G>A, nucleotide position 2149, codon 717, valine>isoleucine.

Results: This patient’s APP mutation has been characterized in several patients prior, but soley associated with the typical early AD features. This is the first case reported with parkinsonism, supranuclear palsy, and dysautonomia.

Conclusions: Features of PSP and MSA may be included to the expanded phenotypic range associated with mutations of APP.

To cite this abstract in AMA style:

J.E. Staisch, M. Padmanaban, J. Mastrianni, T. Xie. A novel phenotype of amyloid precursor protein (APP) mutation presenting with dementia, and symptoms of both progressive supranulcear palsy (PSP) and multisystem atrophy (MSA) [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/a-novel-phenotype-of-amyloid-precursor-protein-app-mutation-presenting-with-dementia-and-symptoms-of-both-progressive-supranulcear-palsy-psp-and-multisystem-atrophy-msa/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/a-novel-phenotype-of-amyloid-precursor-protein-app-mutation-presenting-with-dementia-and-symptoms-of-both-progressive-supranulcear-palsy-psp-and-multisystem-atrophy-msa/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley